✦ LIBER ✦

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

✍ Scribed by Christopher N Hurt; Lisette S Nixon; Gareth O Griffiths; Ruby Al-Mokhtar; Simon Gollins; John N Staffurth; Ceri J Phillips; Jane M Blazeby; Tom D Crosby

Book ID: 115010390
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 214 KB
Volume: 11
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-11-466

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoradiotherapy with or without cetuxi

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

✍ Crosby, Thomas; Hurt, Christopher N; Falk, Stephen; Gollins, Simon; Mukherjee, S 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 374 KB

Mitomycin or cisplatin chemoradiation wi

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

✍ James, Roger D; Glynne-Jones, Robert; Meadows, Helen M; Cunningham, David; Myint 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 247 KB

Randomized Phase III Trial of Concurrent

Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

✍ Ang, K. K.; Zhang, Q.; Rosenthal, D. I.; Nguyen-Tan, P. F.; Sherman, E. J.; Webe 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 637 KB

Gemcitabine with or without continuous i

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

✍ Di Costanzo, F; Carlini, P; Doni, L; Massidda, B; Mattioli, R; Iop, A; Barletta, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phase III Trial of Doxorubicin Plus Cisp

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Fleming, G. F. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

Impact of tumor HPV status on outcome in

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

✍ Vermorken, J. B.; Psyrri, A.; Mesia, R.; Peyrade, F.; Beier, F.; de Blas, B.; Ce 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 176 KB